๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

316 The influence of obstrogen receptor status on the response of metastatic breast cancer to aminoglutehimide

โœ Scribed by A. Aboul-Enein; N. Hansour; I. Ashmawy; Y. Gawish; A. Abboud

Book ID
116003768
Publisher
Elsevier Science
Year
1983
Tongue
English
Weight
115 KB
Volume
19
Category
Article
ISSN
0022-4731

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Influence of estrogen receptor status on
Influence of estrogen receptor status on response of metastatic breast cancer to aminoglutethimide therapy
โœ Dr. Bellarmine V. Lawrence; Allan Lipton; Harold A. Harvey; Richard J. Santen; S ๐Ÿ“‚ Article ๐Ÿ“… 1980 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 563 KB

Aminoglutethimide (AG) is an effective chemical ablative form of therapy for metastatic breast cancer in postmenopausal women. Estrogen receptor (ER) status in breast cancer is useful in predicting the response to the hormonal treatments. Of 134 postmenopausal metastatic breast cancer patients treat

Steroid receptors and response to endocr
Steroid receptors and response to endocrine ablations in women with metastatic cancer of the breast
โœ Thomas L. Dao; Takuma Nemoto ๐Ÿ“‚ Article ๐Ÿ“… 1980 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 384 KB ๐Ÿ‘ 3 views

Estrogen receptors in breast tumors were assayed in 55 premenopausal women undergoing bilateral oophorectomy and in 120 postmenopausal women undergoing bilateral adrenalectomy for treatment of metastatic breast cancer. The data show that 20 (60%) of the 32 patients with estrogen receptor-positive (E